These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2408326)

  • 1. Enriched Langerhans cells express more HLA-DR determinants than blood-derived adherent cells (monocytes and dendritic cells).
    Bjercke S; Gaudernack G; Braathen LR
    Scand J Immunol; 1985 May; 21(5):489-92. PubMed ID: 2408326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficiency of human Langerhans' cells and blood derived dendritic cells as antigen-presenting cells.
    Bjercke S; Braathen L; Gaudernack G; Thorsby E
    Acta Derm Venereol; 1985; 65(5):374-8. PubMed ID: 2416158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells and monocytes as accessory cells in T-cell responses in man. I. Phenotypic analysis of dendritic cells and monocytes.
    Gaudernack G; Bjercke S
    Scand J Immunol; 1985 May; 21(5):493-500. PubMed ID: 3923613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
    Sontheimer RD
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of class II HLA molecules in T cell activation by antigen. Implications for the autologous mixed lymphocyte reaction.
    Thorsby E; Berle E; Scott H; Braathen LR
    Behring Inst Mitt; 1983 May; (72):129-34. PubMed ID: 6100471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-D/DR restriction of Langerhans cell-dependent antigen activation of T lymphocytes. The same D/DR determinants are restriction elements on monocytes and Langerhans cells.
    Berle EJ; Braathen LR; Thorsby E
    Scand J Immunol; 1982 Dec; 16(6):549-52. PubMed ID: 6186017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antigen-presenting function of human Langerhans cells.
    Braathen LR; Bjercke S; Thorsby E
    Immunobiology; 1984 Dec; 168(3-5):301-12. PubMed ID: 6241602
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of human epidermal Langerhans cells in skin immunity.
    Braathen LR
    Derm Beruf Umwelt; 1987; 35(2):58-61. PubMed ID: 2439270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid synovial dendritic cells as stimulators in allogeneic and autologous mixed leukocyte reactions--comparison with autologous monocytes as stimulator cells.
    Waalen K; Thoen J; Førre O; Hovig T; Teigland J; Natvig JB
    Scand J Immunol; 1986 Feb; 23(2):233-41. PubMed ID: 2937138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human epidermal Langerhans cells and peripheral blood monocytes. Accessory cell function, autoactivating and alloactivating capacity and ETAF/IL-1 production.
    Räsänen L; Lehto M; Jansén C; Reunala T; Leinikki P
    Scand J Immunol; 1986 Nov; 24(5):503-8. PubMed ID: 3491421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells.
    Berman B; Duncan MR; Smith B; Ziboh VA; Palladino M
    J Invest Dermatol; 1985 Jan; 84(1):54-8. PubMed ID: 2578172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells.
    Czernielewski JM; Schmitt D; Faure MR; Thivolet J
    Br J Dermatol; 1983 Feb; 108(2):129-38. PubMed ID: 6186266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation.
    Cooper KD; Neises GR; Katz SI
    J Invest Dermatol; 1986 Apr; 86(4):363-70. PubMed ID: 2943821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of HLA class II antigens on human monocytes and its relation to antigen-presenting function].
    Xiong SQ; Feng XW
    Sheng Li Ke Xue Jin Zhan; 1991 Apr; 22(2):159-61. PubMed ID: 1724572
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of MHC class II antigenic determinants in the function of human antigen binding T8+ cells, monocytes and helper and suppressor factors.
    Lehner T; Jones T
    Clin Exp Immunol; 1984 Jun; 56(3):683-93. PubMed ID: 6204796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
    Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of the immune response--findings on the significance of HLA-DR antigens].
    Diezel W; Volc-Platzer B; Volk HD; Stingl G
    Dermatol Monatsschr; 1985; 171(5):303-7. PubMed ID: 3894078
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on human epidermal langerhans cells. IV. HLA-D restriction of langerhans cell-dependent antigen activation of T lymphocytes.
    Braathen LR; Thorsby E
    Scand J Immunol; 1982 Jan; 15(1):55-61. PubMed ID: 6176017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-A, -B, and -DR specificities on human monocytes.
    Merdrignac G; Fauchet R; Bouhallier O; Genetet B
    Tissue Antigens; 1981 Nov; 18(5):299-305. PubMed ID: 6178177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Langerhans cells in antigen presentation.
    Katz SI; Cooper KD; Iijima M; Tsuchida T
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):96s-98s. PubMed ID: 3874249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.